On ECHEMI
Home > Drugs > Bladder cancer
Bladder cancer
Bladder cancer is the most common malignant tumor of the urinary system, and its incidence rate ranks first among malignant tumors of the urinary system. The cause of the disease is still unclear, but it is generally believed to be related to frequent contact with carcinogens such as naphthylamine and benzidine. Dyes, rubber, plastic products, paints, detergents, etc. commonly seen in daily life also have potential carcinogenic risks. Smoking is not only harmful to the respiratory system, but also causes bladder cancer. In addition, certain diseases such as leukoplakia, glandular cystitis, urethral stones, and urine retention may also induce bladder cancer. The incidence rate of bladder cancer in men and women is about 5:2, and there are about 54,500 new cases in the United States each year (estimated in 1997).
  • Site of disease:

    bladder
  • Infectious :

    Not contagious
  • Frequent population:

    Age 51-70
  • Related symptoms:

    Detrusor areflexia pubic mass painless hematuria pururia urination disorder
  • Concurrent disease:

Related Drugs
Gemcitabine Hydrochloride for Injection
Indication: Suitable for the treatment of intermediate and advanced non-small cell lung cancer.
Gemcitabine Hydrochloride for Injection
Indication: Suitable for the treatment of intermediate and advanced non-small cell lung cancer.
Manufacturer:

Harbin Pharmaceutical Group Bioengineering Co., Ltd.

Gemcitabine Hydrochloride for Injection
Indication: Suitable for the treatment of intermediate and advanced non-small cell lung cancer.
Manufacturer:

Harbin Pharmaceutical Group Bioengineering Co., Ltd.

Gemcitabine Hydrochloride for Injection
Indication: Suitable for the treatment of intermediate and advanced non-small cell lung cancer.
Manufacturer:

Harbin Reputation Scale Pharmaceutical Co., Ltd.

Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Fluorouracil Injection
Indication: This product has a wide anti-tumor spectrum and is mainly used to treat digestive tract tumors or high-dose fluorouracil to treat choriocarcinoma. It is also commonly used to treat breast cancer, ovarian cancer, lung cancer, cervical cancer, bladder cancer and skin cancer.
Fluorouracil Injection
Indication: This product has a wide anti-tumor spectrum and is mainly used to treat digestive tract tumors or high-dose fluorouracil to treat choriocarcinoma. It is also commonly used to treat breast cancer, ovarian cancer, lung cancer, cervical cancer, bladder cancer and skin cancer.
Manufacturer:

Shanxi Taiyuan Pharmaceutical Co., Ltd.

Fluorouracil Injection
Indication: This product has a wide anti-tumor spectrum and is mainly used to treat digestive tract tumors or high-dose fluorouracil to treat choriocarcinoma. It is also commonly used to treat breast cancer, ovarian cancer, lung cancer, cervical cancer, bladder cancer and skin cancer.
Fluorouracil for injection
Indication: 1. This product can be used for adjuvant and palliative treatment of breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system tumors and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma; 2. It can be used to treat malignant hydatidiform mole and choriocarcinoma; 3. It can be used for intensive intra-arterial chemotherapy of serous cavity cancerous effusion and bladder cancer; 4. It can be used for intra-arterial catheter chemotherapy of head and neck malignant tumors and liver cancer.
Manufacturer:

Hainan Changan International Pharmaceutical Co., Ltd.

Fluorouracil for injection
Indication: 1. This product can be used for adjuvant and palliative treatment of breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system tumors and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma; 2. It can be used to treat malignant hydatidiform mole and choriocarcinoma; 3. It can be used for intensive intra-arterial chemotherapy of serous cavity cancerous effusion and bladder cancer; 4. It can be used for intra-arterial catheter chemotherapy of head and neck malignant tumors and liver cancer.
Manufacturer:

Hainan Changan International Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.